Basic Information
Basic information for AL583827.1-202-65aa
Peptide Name AL583827.1-202-65aa
Genome Position chr9:85402547-85402672,85443856-85443924[-]
Species Human
Peptide Sequence MPCLAPVKDGLLFCLLKPTQLAWSFKCENTFQLQDQRTFPTAHKCLQLYRICKSTKESTSYCSRF
Peptide Length 65
Unique No (AL583827.1-201-65aa,AL583827.1-204-65aa,AL583827.1-203-65aa)
Grand Average of Hydropathicity -0.2215
Relative Molecular Mass 8719.07
Experimental Evidences no
lncRNA ID/Name ENSG00000285634;AL583827.1
Transcript ID/Name ENST00000669133;AL583827.1-202
Transcript Length 3652
Coding Ability 0.4926
DNA Sequence Corresponding to Peptide ATGCCATGCCTTGCTCCAGTGAAGGACGGACTGCTGTTCTGTCTCCTAAAACCCACACAGCTCGCCTGGAGCTTCAAATGTGAGAACACATTCCAGCTGCAGGATCAGAGGACTTTTCCTACAGCCCATAAGTGCCTGCAGCTCTATCGGATTTGCAAATCTACAAAAGAGAGCACATCCTATTGTTCCCGGTTT
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :